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Background: In the postpartum cow, early diagnosis of uterine disease is currently problematic due to the lack of
reliable, non-invasive diagnostic methods. Cervico-vaginal mucus (CVM) is an easy to collect potentially informative
source of biomarkers for the diagnosis and prognosis of uterine disease in cows. Here, we report an improved method
for processing CVM from postpartum dairy cows for the measurement of immune biomarkers. CVM samples were
collected from the vagina using gloved hand during the first two weeks postpartum and processed with buffer alone
or buffer containing different concentrations of the reducing agents recommended in standard protocols:
Dithiothriotol (DTT) or N-Acetyl-L-Cysteine (NAC). Total protein was measured using the bicinchoninic acid (BCA) assay;
interleukin 6 (IL-6), IL-8 and α1-acid glycoprotein (AGP) were measured by ELISA.
Results: We found that use of reducing agents to liquefy CVM affects protein yield and the accuracy of biomarker
detection. Our improved protocol results in lower protein yields but improved detection of cytokines and chemokines.
Using our modified method to measure AGP in CVM we found raised levels of AGP at seven days postpartum in CVM
from cows that went on to develop endometritis.
Conclusion: We conclude that processing CVM without reducing agents improves detection of biomarkers that reflect
uterine health in cattle. We propose that measurement of AGP in CVM during the first week postpartum may identify
cows at risk of developing clinical endometritis.
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The postpartum bovine uterus is susceptible to diverse
pathologies including viral and bacterial infection as well as
endometritis, all of which impact negatively on the health,
productivity and fertility of cows [1–3]. Current diagnostic
methods for predicting uterine inflammation such as uter-
ine cytology and biopsy require specialist expertise and
invasive tools. In contrast, CVM could provide a useful
resource for the analysis of uterine health. CVM is
composed of a mixture of oviductal, uterine, cervical and
vaginal secretions and their production is influenced by
health status, the microbiome and pregnancy [2, 4, 5].* Correspondence: kieran.meade@teagasc.ie
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invasive analyses.
Cytokines, e.g. interleukin 6 (IL-6), chemokines e.g. IL-8
and acute phase proteins e.g. α1-Acid Glycoprotein
(AGP), produced by endometrial epithelial cells and local
immune populations are increased in inflamed uterine
tissue and in vitro models [6–8]. These inflammatory
biomarkers have been detected in uterine mucus and
CVM [8–10]. Due to the physical properties of mucus,
processing of CVM with reducing agents is routinely
recommended before the analysis of soluble-phase bio-
markers [4, 9, 11]. N-acetyl-L-cysteine (NAC) and Dithio-
threitol (DTT) are commonly used to homogenize mucus
by reducing the disulfide bonds of mucins [12–14]. How-
ever, many immune biomarkers also have disulfide bonds
[15, 16] and their detection is likely to be compromised by
use of reducing agents. The overall objective of thele is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
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CVM for measuring candidate biomarkers that may pre-
dict uterine inflammation and disease.
Results
Total protein and SDS-PAGE electrophoresis
The standard protocol (with DTT) resulted in higher
levels of total protein than the modified protocol (Fig. 1a).
To determine which protocol best preserves the integrity
of proteins with molecular weights of the candidate cyto-
kines, protocols were compared based on the protein pat-
tern within the range of 10–35 KDa (Fig. 2b) and results
are shown in Fig. 2a (red box). Furthermore, processing
mucus without reducing agent gave denser band patterns
for proteins with large molecular weight (> 130 KDa).
Measurement IL6, IL8 and AGP
Our modified protocol resulted in the detection of sig-
nificantly higher levels of both IL-6 and IL-8 in postpar-
tum CVM per ml of mucus (P < 0.001) (Fig. 1b and c).
Accounting for total protein concentration in each sam-
ple, the concentration of IL-6 and IL-8 per mg of total
protein was also significantly higher in the modified
protocol compared to the standard protocol (P < 0.001)
(Fig. 1d and e).
AGP levels in CVM processed without reducing agent
were higher in cows which went on to develop clinical
endometritis compared to healthy cows (P < 0.05) (Fig. 3).Fig. 1 a Total protein levels in CVM from 16 cows at first two weeks postp
modified protocol and the standard protocol (with DTT). b, c IL-6 and IL-8
to the volume of mucus analyzed. d, e taking in consideration the amount
mg of total protein in the mucus. Results are presented as mean ± SEM an
calculated. ***P < 0.001, **P < 0.01 and *P < 0.05Discussion
Here we demonstrated that use of reducing agents during
the processing of CVM impacts on the accurate detection
of proteins and biomarkers. The standard protocol (with
DTT) resulted in higher levels of total protein than the
modified protocol, since DTT is a powerful reducing
agent that homogenizes mucus through the reduction of
disulfide bounds. Due to the low level of circulating estro-
gen, postpartum mucus is characterized by high viscosity
[5, 17]. For this reason, we believe that DTT used in
standard protocols resulted in higher levels of total protein
as it helped to breakdown disulfide bonds of the viscous
mucins and made protein accessible for measurement by
BCA assay. Thus, if for any reason the use of reducing
agent is required, it is important to determine the lowest
concentration that does not interfere with the marker
being assessed.
SDS-PAGE confirmed that use of reducing agent
affected the stability of proteins in CVM. CVM samples
were run using non-reducing loading buffer to limit
interaction with the effect of the reducing agent used for
processing mucus. Within the molecular weight range of
the main inflammatory cytokines, the protein bands
were denser in the modified protocol indicating that
they contain higher levels of proteins at this molecular
weight. SDS-PAGE shown that for high molecular
weight proteins, such as acute phase proteins and mu-
cins, both reducing agents should be avoided as theseartum were measured using BCA assay and compared between our
levels were measured by ELISA and results were presented according
of total protein (TP) in CVM, IL-6 and IL-8 levels were presented per
d analyzed by t test. Significant differences between groups are
Fig. 2 a CVM from 16 cows was processed by different protocols, from the top: modified protocol without reducing agent, standard protocol
with NAC and standard protocol with DTT. Total protein was analyzed by SDS-PAGE using 4–20% gradient running gel and non-reducing loading
buffer to illustrate the protein bands within the range of main inflammatory biomarkers (red box). Different amount of methanol was added. Each
protein column from the SDS-PAGE gel corresponds to a bar in the BCA assay graphs. b Molecular weight of main inflammatory biomarkers
implicated in uterine inflammation; interleukin 1-α, IL-1β, Tumor necrosis factor alpha (TNFα), IL-6, α-1-acid glycoprotein (AGP), IL-10, chemokine
(C-X-C motif) ligand 8 (CXCL-8/IL-8) and Chemokine (C-C motif) ligand 5 (CCL-5). ND: not defined. KDa; kilodalton.*www.uniprot.org
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not be accurately measured by ELISA.
Our modified protocol resulted in the detection of sig-
nificantly higher levels of both IL-6 and IL-8 in postpar-
tum CVM. As proteins, cytokines, chemokines and
acute phase proteins contain disulfide bonds between
the cysteine residues, and the use of reducing agent may
affect the stability of these proteins and decrease their
detection using ELISA technique. For example, the IL-6
protein contains 4 cysteine residues, which areconserved between different species (i.e. human and
cow) and are connected by 2 disulfide bonds (Cys
44-Cys 50 and Cys 73-Cys 83) [18, 19]. The two disulfide
bridges can be reduced and alkylated under chemical
reduction [20] or non-denaturing conditions [21].
Therefore, reducing agents decrease the stability of IL-6
and may decrease its detection by antibodies, since the
disulfide bonds seem to be responsible for maintaining
structural integrity of receptor binding sites rather than
conformational stability [20, 21]. In a previous study at
Fig. 3 CVM mucus from 20 cows at 7 days postpartum was processed
without reducing agent and α1-acide glycoprotein (AGP) levels were
measured using ELISA. AGP level was presented according to the
amount of total protein (TP) in CVM. Results are presented as mean ±
SEM and analyzed by t test. Significant differences between groups are
calculated. *P < 0.05
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detectable concentration of IL-6 standard [15]. Like-
wise, IL-8 contains 4 cysteines that form 2 disulfide
bonds and it is rapidly inactivated when their disul-
fide bonds are reduced [22] which would decrease its
detection by ELISA.
Increased AGP levels are associated with uterine infec-
tion and have been proposed to be prognostic of endomet-
ritis [23, 24]. To validate our improved protocol to identify
pathological inflammation, AGP was measured in CVM
collected at seven days postpartum from 20 cows, 10 of
which went on to develop endometritis. CVM processed
with the modified protocol resulted in higher levels of AGP
in cows which went on to develop clinical endometritis,
compared to healthy cows. AGP has two disulfide bounds
between cysteine (Cys) Cys5-Cys165 and Cys72-Cys147
[25] and use of reducing agent would breakdown these
bounds and decrease the detection of AGP. Likewise, DTT
was confirmed to reduce the molecular weight of pig AGP
when it used for 2D electrophoresis [26]. Using our im-
proved protocol to measure AGP in CVM to predict cows
at risk of developing clinical endometritis, we found that
the test could have a sensitivity of 70% and specificity of
100%. Thus, all cows positively identified at day 7 developed
clinical endometritis at 21 DPP. These findings could help
to reduce antibiotic use by reducing the numbers of cattle
treated using CVM diagnosis alone, as well as reducing the
costs associated with reproductive diseases.
Conclusion
Here we show that processing CVM without any redu-
cing agent allows for more accurate measurement of in-
flammatory biomarkers in early postpartum mucus. Wealso show that raised AGP levels predict cows at risk of
developing clinical endometritis. Thus, the improved de-
tection of biomarkers in CVM from the postpartum cow
represents a technique with significant practical utility
for early disease diagnosis in a non-invasive and welfare
friendly manner.
Methods
Herd identification
Material was obtained from 36 mixed-parity Holstein-
Friesian dairy cows during their first two weeks postpartum.
Animals used in this study belong to three commercial
dairy farms. Among these cows, 16 belong to one farm
were used to measure IL-6 and IL-8, and 20 cows from two
different farms were diagnosed for clinical endometritis by
scoring mucus aspect and odor at day 21 postpartum [24]
and used to measure AGP levels. All animals were exam-
ined in their normal farming conditions and they remain
on farm after the samples were collected.
Vaginal mucus collection
Vaginal examination and mucus collection were per-
formed according to a previously described protocol [27].
Briefly, using examination sleeves, the perineum was
wiped and washed with 70% ethanol to remove fecal ma-
terial. An examination sleeve was covered with clean sur-
gical glove and the gloved hand was inserted through the
vulva into the vagina and CVM was collected and scored
as described by Williams et al. (2005). CVM was collected
in an empty sterile 20 ml tube and immediately placed on
ice and transported to the laboratory within 4-6 h.
CVM processing
CVM collected from 16 cows from one farm was used
to optimize the technique and processed using two dif-
ferent protocols: the standard protocol using reducing
agent (DTT) [9, 15] and our modified protocol without
reducing agent. In the modified protocol, CVM was cen-
trifuged at 3000 x g for 15 min at 4 °C and 500 μl of the
upper part was collected and mixed with 1000 μl of ster-
ile PBS in 2 ml eppendorf tubes and vortexed. In the
standard protocol (with DTT), CVM was processed ac-
cording to Cronin et al. (2010). Briefly, 2 g of frozen
CVM was added to 10 ml of cytolyt solution (40%
methanol: 60% distilled water) and mixed with 1 mM
DTT to disrupt the mucus. Tubes were then centrifuged
at 3000 x g for 15 min at 4 °C. The supernatant was col-
lected and multiple aliquots of 1 ml were prepared and
used to measure IL-6, IL-8 and AGP by ELISA.
CVM from one cow was selected for further analysis
using a second reducing agent NAC [15]. In the modi-
fied protocol, 500 mg from frozen CVM were mixed
with 1000 μl of PBS. In the standard protocol, 500 mg of
frozen CVM were mixed with 1000 μl PBS in 5 ml tubes
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500 μl) or DTT (20, 50, 100, 200 μl) were added to each
tube. Tubes were centrifuged at 3000 x g at 4 °C for
15 min and the supernatant was collected and aliquoted
into Eppendorf tubes and stored at − 80 °C for further
analysis by BCA assay for total protein and SDS-PAGE.
Measurement of total protein
Total protein levels in CVM were measured using a
bicinchoninic acid (BCA) assay using a commercially
available kit (Pierce™ BCA Protein Assay Kit (#23227,
ThermoScientific®, 3747 N. Meridian Rd. Rockford, IL
61101, United States) according to manufacturer’s guide-
lines. Briefly, the contents of one albumin standard
(BSA) ampule was diluted with PBS into eight standards
and one blank. The working reagent was prepared by
mixing 50 parts of BCA reagent A with 1 part of BCA
reagent B (50:1, Reagent A: B). Then, 25 μL of each
standard or sample were added in duplicate into a mi-
croplate well. 200 μL of the working reagent was added
to each well and the 96 well plate was mixed thoroughly
on a plate shaker for 30 s. The plate was then covered
and incubated at 37 °C for 30 min. After cooling the
plate, the absorbance was measured at 562 nm on a
plate reader (GloMax®-Multi Detection System, Promega
Corporation, 2800 Woods Hollow Road Madison, WI
53711 USA).
SDS-PAGE electrophoresis
To visualize the range of proteins in mucus, a gradient
running gel 4–20% was chosen in combination with a
5% stacking gel. To not interact with the effect of the re-
ducing agent added to the mucus, samples were loaded
in the gel cassette using non-reducing loading buffer.
Gels were run at 110 V for 90 min and then stained with
Coomassie blue G250 for one hour with gentle agitation.
After overnight distaining in 10% glacial acetic acid, gels
were scanned and interpreted.
Measurement IL6, IL8 and AGP
After thawing, samples were centrifuged at 3000 x g for
15 min at 4 °C and the supernatant was used to measure
biomarkers. Levels of IL-6, IL-8 and AGP in CVM were
measured using commercial ELISA kits (human IL-8
ELISA kit: R&D Systems Inc., Minneapolis, Minnesota,
USA; bovine IL-6 ELISA kit: #ESS0029, ThermoScienti-
fic®, 3747 N. Meridian Rd. Rockford, IL 61101; Cow
AGP: #AGP-11, Life Diagnostics Inc.®, P.O. Box 5205,
West Chester, Pa. 19380) according to the guidelines
provided by the manufacturers and modified according to
previous studies in bovine [6, 9, 10]. Human IL-8 ELISA
was used because no bovine specific IL-8 ready-to-use
ELISA is commercially available. Furthermore, the anti-
bodies used in the kit have been confirmed to cross-reactwith bovine IL-8 [6, 28]. To validate the usefulness of the
improved protocol to detect uterine health problems,
AGP was measured in CVM from 20 animals of which 10
developed clinical endometritis.
Statistical analysis
Statistical analysis was performed using GraphPad® Prism
5 software (GraphPad Software, Inc. 7825 Fay Avenue,
Suite 230 La Jolla, CA 92037 USA). A Students t test was
used to compare results between two groups, while
one-way ANOVA with Bonferroni post-comparison test
was used to compare between three or more groups.
Results were presented as mean ± SEM and considered
statistically significant at P-value < 0.05.
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